Breast Cancer Therapy
Chemotherapy side effects improve over time but not by addition of hormone therapy
Published in Drug Week, January 6th, 2006
According to scientists in Canada, "We previously evaluated fatigue, menopausal symptoms, and cognitive dysfunction in patients receiving adjuvant therapy for breast cancer and matched healthy women. We [now] report assessment of these women 1 and 2-years later."
H.G. Fan and colleagues wrote, "Patients without relapse and controls were evaluated by the Functional Assessment of Cancer Treatment-General Quality of Life questionnaire, with subscales for fatigue and endocrine symptoms, and by the High Sensitivity Cognitive Screen....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-01-06)
More Articles from Drug Week
- Breast Cancer
Encouraging results presented on Advexin - Cancer Therapy
Hycamtin receives positive opinion for treatment of patients with relapsed small cell lung cancer - Depression
New drug increases endocannabinoids, provides anti-depressant effect - Drug Development
LymphoStat-B meets primary endpoints in phase II trial of patients with rheumatoid arthritis - Heart Failure
Levosimendan trial in patients with acute decompensated heart failure did not meet primary endpoint - Herpesvirus
Study suggests not all marketed aciclovir creams are bioequivalent - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
